DRD2 and autism: Downregulation of DRD2 has been shown to activate AKT-mTOR (mammalian target of rapamycin) signaling (Fig. 4a)41,42, and activation of mTOR signaling has been implicated in the deficient synaptic pruning in the autism-spectrum diseases9.